Next Article in Journal
Development of an Intranasal In Situ System for Ribavirin Delivery: In Vitro and In Vivo Evaluation
Next Article in Special Issue
Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients
Previous Article in Journal
Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in Augmented Therapy
Previous Article in Special Issue
Pharmacokinetic Simulation and Area under the Curve Estimation of Drugs Subject to Enterohepatic Circulation
 
 
Review

Article Versions Notes

Pharmaceutics 2024, 16(9), 1124; https://doi.org/10.3390/pharmaceutics16091124
Action Date Notes Link
article html file updated 13 September 2025 12:36 CEST Update https://www.mdpi.com/1999-4923/16/9/1124/html
article html file updated 25 August 2025 00:51 CEST Update -
article html file updated 26 June 2025 15:43 CEST Update -
article html file updated 26 August 2024 11:38 CEST Update -
article pdf uploaded. 26 August 2024 11:36 CEST Updated version of record https://www.mdpi.com/1999-4923/16/9/1124/pdf
article xml uploaded. 26 August 2024 11:36 CEST Update https://www.mdpi.com/1999-4923/16/9/1124/xml
article xml file uploaded 26 August 2024 11:36 CEST Update -
article html file updated 26 August 2024 10:43 CEST Original file -
article pdf uploaded. 26 August 2024 10:40 CEST Version of Record -
article xml uploaded. 26 August 2024 10:40 CEST Update -
article xml file uploaded 26 August 2024 10:40 CEST Original file -
Back to TopTop